StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.82+0.05 (+0.74%)

Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –

Arvinas enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Arvinas's enterprise value was -$116.18M on Nov 11, 2026, against $104.02M a year earlier. Over the last 5 years it ranged from -$555.62M to $2.79B, with a median of $210.85M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$116.18M-320.5%
2025Dec 31, 2025$52.69M-73.1%
2024Dec 31, 2024$196.18M-84.5%
2023Dec 29, 2023$1.27B+130.1%
2022Dec 30, 2022$550.27M-80.2%
2021Dec 31, 2021$2.79B-11.8%
2020Dec 31, 2020$3.16B+169.8%
2019Dec 31, 2019$1.17B–
2018Dec 31, 2018-$40.26M–

More Arvinas figures

See a number that looks wrong?